David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Just One Number Will Convince You Not to Buy Zoom Stock

By David Moadel, InvestorPlace Contributor

It's okay to like the company, but if traditional valuation metrics mean anything anymore, then you might want to avoid ZM stock for now.

There’s No Real Value Left in Whiting Petroleum Stock

By David Moadel, InvestorPlace Contributor

Sadly, a once mighty oil company is now going bankrupt. Knowing this, there's no need to gamble on fast-falling WLL stock.

There’s Room to Own Nikola Shares Even If You Like Tesla

By David Moadel, InvestorPlace Contributor

The media likes to pit Tesla fans against Nikola enthusiasts. Yet, investors can own Nikola stock and Tesla shares at the same time.

Toss Taoping Stock Off Your Watch List Despite Cloud Connection

By David Moadel, InvestorPlace Contributor

At the intersection of big data and cloud management stands this Chinese start-up. That sounds promising, but Taoping stock is falling fast.

Royalty Pharma Is the Left-Field Investment You’re Missing Out On

By David Moadel, InvestorPlace Contributor

You'll have a rare chance to capitalize on two highly lucrative markets as Royalty Pharma stock profits from drugmakers in a different way.

Load More